Cabaletta Bio, Inc.
CABA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $4,813 | $1,426 | $3,684 | $733 |
| Gross Profit | -$4,813 | -$1,426 | -$3,684 | -$733 |
| % Margin | – | – | – | – |
| R&D Expenses | $97,203 | $55,424 | $39,300 | $32,494 |
| G&A Expenses | $0 | $19,236 | $0 | $0 |
| SG&A Expenses | $23,125 | $19,236 | $11,155 | $13,086 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$1,426 | $0 | $0 |
| Operating Expenses | $120,328 | $73,234 | $50,455 | $45,580 |
| Operating Income | -$125,141 | -$74,660 | -$54,139 | -$46,313 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $9,277 | $6,985 | $1,164 | $24 |
| Pre-Tax Income | -$115,864 | -$67,675 | -$52,975 | -$46,289 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$115,864 | -$67,675 | -$52,975 | -$46,289 |
| % Margin | – | – | – | – |
| EPS | -2.34 | -1.65 | -1.81 | -1.8 |
| % Growth | -41.8% | 8.8% | -0.6% | – |
| EPS Diluted | -2.34 | -1.65 | -1.81 | -1.8 |
| Weighted Avg Shares Out | 49,524 | 40,946 | 29,343 | 25,737 |
| Weighted Avg Shares Out Dil | 49,471 | 40,946 | 29,343 | 25,737 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10,025 | $6,985 | $1,164 | $24 |
| Interest Expense | $748 | $0 | $0 | $0 |
| Depreciation & Amortization | $4,813 | $1,426 | $3,684 | $733 |
| EBITDA | -$110,303 | -$66,249 | -$49,291 | -$45,556 |
| % Margin | – | – | – | – |